Cost effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada

被引：0

作者：

Mouallif, Soukaina ^{[1
]}

Thomas, Kim ^{[2
]}

Adlard, Nicholas ^{[3
]}

Cooney, Philip ^{[4
]}

Blanchette, Francois ^{[1
]}

Patel, Barkha ^{[2
]}

Baharnoori, Moogeh ^{[5
]}

Bhan, Virender ^{[6
]}

Clift, Fraser ^{[7
]}

Grima, Daniel ^{[2
]}

机构：

[1] Novartis Pharmaceut Canada Inc, Dorval, PQ, Canada

[2] Eversana, Chicago, IL USA

[3] Novartis Pharma AG, Basel, Switzerland

[4] Novartis Ireland Ltd, Dublin, Ireland

[5] Queens Univ, Dept Med, Kingston, ON, Canada

[6] Univ British Columbia, Vancouver, BC, Canada

[7] Mem Univ Newfoundland, Dept Neurol, St John, NF, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页数：3